{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:21:44Z","timestamp":1794007304355,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006188","name":"Einstein Foundation Berlin","doi-asserted-by":"crossref","award":["EVF-BUA-2022-694"],"award-info":[{"award-number":["EVF-BUA-2022-694"]}],"id":[{"id":"10.13039\/501100006188","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postpartum hemorrhage (PPH) is one of the leading causes of maternal morbidity and mortality worldwide. Intrauterine hemostatic devices are recommended when PPH does not respond to medical treatment. The objective of this study was to assess the factors leading to unsuccessful intrauterine therapy with a chitosan-covered tamponade (CT) for the treatment of PPH and to evaluate clinical outcomes based on real-world data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This registry-based cohort study included all women treated with CT for PPH between January 2017 and June 2022 at a university clinic\u2019s perinatal department. The endpoint was defined as the failure of CT, indicated by the requirement of further invasive procedures for ongoing hemorrhage after CT application. Medical records were reviewed and binary logistic regressions used to evaluate delivery mode, placenta previa, and placenta accreta spectrum as potential risk factors for CT treatment failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort consisted of 230 women, with successful CT treatment in 91.3%. The success rate for mild PPH was 100.0%, for moderate 95.5%, and for severe 84.2%. Five hysterectomies were performed in total. Placenta previa in cesarean sections was identified as the primary risk factor for CT treatment failure, increasing the odds about 7.5-fold (Odds Ratio: 7.48; 95% CI: 1.87\u201333.15) compared to cesarean sections without placenta previa. Furthermore, delays in CT insertion may also contribute to treatment failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CT serves as an intrauterine treatment for medically intractable PPH. Placenta previa significantly increases the risk of CT treatment failure in cesarean sections. Obstetricians should be particularly vigilant in managing patients with placenta previa and consider early use of CT or a combination of procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This study was approved by the local Ethics Committee on 11\/10\/2021 (EA4\/231\/21).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-025-07236-5","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:22:21Z","timestamp":1738732941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Chitosan-covered tamponade for the treatment of postpartum hemorrhage: a registry-based cohort study assessing outcomes and risk factors for treatment failure"],"prefix":"10.1186","volume":"25","author":[{"given":"Clara","family":"Leichtle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Biele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Dangli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Waldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Henrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"D\u00fcckelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"7236_CR1","unstructured":"World Health Organization. A roadmap to combat postpartum haemorrhage between 2023 and 2030. Geneva: WHO; 2023. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/373221\/9789240081802-eng.pdf. Licence: CC BY-NC-SA 3.0 IGO. Assessed 27 Oct 2024."},{"issue":"6","key":"7236_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.bpobgyn.2008.08.004","volume":"22","author":"G Carroli","year":"2008","unstructured":"Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008;22(6):999\u20131012.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"7236_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1053\/j.semperi.2011.09.010","volume":"36","author":"S Haeri","year":"2012","unstructured":"Haeri S, Dildy GA 3. Maternal mortality from hemorrhage. Semin Perinatol. 2012;36(1):48\u201355.","journal-title":"Semin Perinatol"},{"issue":"6","key":"7236_CR4","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","volume":"2","author":"L Say","year":"2014","unstructured":"Say L, Chou D, Gemmill A, Tun\u00e7alp \u00d6, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323-333.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"7236_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001466","volume":"4","author":"JP Vogel","year":"2019","unstructured":"Vogel JP, Williams M, Gallos I, Althabe F, Oladapo OT. WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and which one? BMJ Glob Health. 2019;4(2): e001466.","journal-title":"BMJ Glob Health"},{"key":"7236_CR6","unstructured":"World Health Organization. WHO recommendation on routes of oxytocin administration for the prevention of postpartum haemorrhage after vaginal birth. Geneva: WHO; 2020. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/75411\/9789241548502_eng.pdf. Assessed 27 Oct 2024."},{"key":"7236_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2147\/IJWH.S366675","volume":"15","author":"LY Liu","year":"2023","unstructured":"Liu LY, Nathan L, Sheen JJ, Goffman D. Review of current insights and therapeutic approaches for the treatment of refractory postpartum hemorrhage. Int J Womens Health. 2023;15:905\u201326.","journal-title":"Int J Womens Health"},{"key":"7236_CR8","unstructured":"Institute for Global Health Sciences. Defining research priorities for non-balloon intrauterine PPH management tools 2024. Available from: https:\/\/globalhealthsciences.ucsf.edu\/our-work\/health-challenges\/reproductive-maternal-and-newborn-health\/defining-research-priorities-for-non-balloon-intrauterine-pph-management-tools\/. Assessed 27 Oct 2024."},{"issue":"3s","key":"7236_CR9","doi-asserted-by":"publisher","first-page":"S1076","DOI":"10.1016\/j.ajog.2023.08.015","volume":"230","author":"E Overton","year":"2024","unstructured":"Overton E, D\u2019Alton M, Goffman D. Intrauterine devices in the management of postpartum hemorrhage. Am J Obstet Gynecol. 2024;230(3s):S1076-88.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"7236_CR10","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1080\/17434440.2021.1962288","volume":"18","author":"M D\u2019Alton","year":"2021","unstructured":"D\u2019Alton M, Rood K, Simhan H, Goffman D. Profile of the Jada\u00ae System: the vacuum-induced hemorrhage control device for treating abnormal postpartum uterine bleeding and postpartum hemorrhage. Expert Rev Med Devices. 2021;18(9):849\u201353.","journal-title":"Expert Rev Med Devices"},{"issue":"3s","key":"7236_CR11","doi-asserted-by":"publisher","first-page":"S1061","DOI":"10.1016\/j.ajog.2022.11.1297","volume":"230","author":"W Henrich","year":"2024","unstructured":"Henrich W, D\u00fcckelmann A, Braun T, Hinkson L. Uterine packing with chitosan-covered tamponade to treat postpartum hemorrhage. Am J Obstet Gynecol. 2024;230(3s):S1061-5.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"7236_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0003-4975(10)60649-2","volume":"36","author":"WG Malette","year":"1983","unstructured":"Malette WG, Quigley HJ, Gaines RD, Johnson ND, Rainer WG. Chitosan: a new hemostatic. Ann Thorac Surg. 1983;36(1):55\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"7236_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P","volume":"34","author":"SB Rao","year":"1997","unstructured":"Rao SB, Sharma CP. Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res. 1997;34(1):21\u20138.","journal-title":"J Biomed Mater Res"},{"issue":"1","key":"7236_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/md8010024","volume":"8","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Park RD, Muzzarelli RA. Chitin deacetylases: properties and applications. Mar Drugs. 2010;8(1):24\u201346.","journal-title":"Mar Drugs"},{"issue":"1","key":"7236_CR15","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/j.ajog.2011.09.018","volume":"206","author":"BC Schmid","year":"2012","unstructured":"Schmid BC, Rezniczek GA, Rolf N, Maul H. Postpartum hemorrhage: use of hemostatic combat gauze. Am J Obstet Gynecol. 2012;206(1):e12-3.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"7236_CR16","doi-asserted-by":"publisher","first-page":"e2251","DOI":"10.1016\/j.ajog.2013.05.055","volume":"209","author":"BC Schmid","year":"2013","unstructured":"Schmid BC, Rezniczek GA, Rolf N, Saade G, Gebauer G, Maul H. Uterine packing with chitosan-covered gauze for control of postpartum hemorrhage. Am J Obstet Gynecol. 2013;209(3):e2251-2255.","journal-title":"Am J Obstet Gynecol"},{"key":"7236_CR17","doi-asserted-by":"crossref","unstructured":"Beckerath AK. Use of chitosan-covered gauze (Celox) in 98 cases of severe postpartum hemorrhage\u2013a multicenter registry analysis. Am J Obstet Gynecol.\u00a02016;214(1):S269.","DOI":"10.1016\/j.ajog.2015.10.535"},{"key":"7236_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejogrb.2019.06.003","volume":"240","author":"AM Dueckelmann","year":"2019","unstructured":"Dueckelmann AM, Hinkson L, Nonnenmacher A, Siedentopf JP, Schoenborn I, Weizsaecker K, et al. Uterine packing with chitosan-covered gauze compared to balloon tamponade for managing postpartum hemorrhage. Eur J Obstet Gynecol Reprod Biol. 2019;240:151\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"7236_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2024.2354382","volume":"37","author":"AM Dueckelmann","year":"2024","unstructured":"Dueckelmann AM, Hermann P, Biele C, Leichtle C, Waldner C, Braun T, et al. Short and long-term menstrual, reproductive, and mental health outcomes after the intrauterine use of chitosan tamponade or the Bakri balloon for severe postpartum hemorrhage: an observational study. J Matern Fetal Neonatal Med. 2024;37(1): 2354382.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"8","key":"7236_CR20","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1515\/jpm-2021-0533","volume":"50","author":"C Biele","year":"2022","unstructured":"Biele C, Radtke L, Kaufner L, Hinkson L, Braun T, Henrich W, et al. Does the use of chitosan covered gauze for postpartum hemorrhage reduce the need for surgical therapy including hysterectomy? A databased historical cohort study. J Perinat Med. 2022;50(8):1078\u201386.","journal-title":"J Perinat Med"},{"key":"7236_CR21","first-page":"e106","volume":"124","author":"E Mavrides","year":"2016","unstructured":"Mavrides E, Allard S, Chandraharan E, Collins P, Green L, Hunt BJ, Riris S, Thomson AJ on behalfof the Royal College of Obstetricians and gynaecologists. Prevention and management of postpartum haemorrhage. BJOG. 2016;124:e106-49.","journal-title":"BJOG"},{"issue":"12","key":"7236_CR22","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1055\/a-2073-9615","volume":"83","author":"D Schlembach","year":"2023","unstructured":"Schlembach D, Helmer H, Henrich W, von Heymann C, Kainer F, Korte W, et al. Peripartum haemorrhage, diagnosis and therapy. Guideline of the DGGG, OEGGG and SGGG (S2k, AWMF Registry No. 015\u2013063, August 2022). Geburtshilfe und Frauenheilkunde Georg Thieme Verlag. 2023;83(12):1446\u201390.","journal-title":"Geburtshilfe und Frauenheilkunde Georg Thieme Verlag"},{"key":"7236_CR23","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2021. Available from: https:\/\/www.r-project.org\/. Assessed 22 Sep 2024."},{"key":"7236_CR24","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan L, Fran\u00e7ois R, et al. Welcome to the tidyverse. J Open Source Softw. 2019;4:1686.","journal-title":"J Open Source Softw"},{"issue":"5","key":"7236_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jvir.2013.02.013","volume":"24","author":"YJ Kim","year":"2013","unstructured":"Kim YJ, Yoon CJ, Seong NJ, Kang SG, An SW, Kim YS, et al. Failed pelvic arterial embolization for postpartum hemorrhage: clinical outcomes and predictive factors. J Vasc Interv Radiol. 2013;24(5):703\u20139.","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"7236_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206663","volume":"13","author":"J Grange","year":"2018","unstructured":"Grange J, Chatellier M, Chev\u00e9 MT, Paumier A, Launay-Bourillon C, Legendre G, et al. Predictors of failed intrauterine balloon tamponade for persistent postpartum hemorrhage after vaginal delivery. PLoS One. 2018;13(10): e0206663.","journal-title":"PLoS One"},{"issue":"1","key":"7236_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12884-021-03818-1","volume":"21","author":"CN Liu","year":"2021","unstructured":"Liu CN, Yu FB, Xu YZ, Li JS, Guan ZH, Sun MN, et al. Prevalence and risk factors of severe postpartum hemorrhage: a retrospective cohort study. BMC Pregnancy Childbirth. 2021;21(1):332.","journal-title":"BMC Pregnancy Childbirth"},{"key":"7236_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ejogrb.2022.11.021","volume":"280","author":"AM Angarita","year":"2023","unstructured":"Angarita AM, Cochrane E, Bianco A, Berghella V. Prevention of postpartum hemorrhage in vaginal deliveries. Eur J Obstet Gynecol Reprod Biol. 2023;280:112\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"7236_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/healthcare9030295","volume":"9","author":"FJ Ruiz Labarta","year":"2021","unstructured":"Ruiz Labarta FJ, Pintado Recarte MP, Joigneau Prieto L, Bravo Arribas C, Bujan J, Ortega MA, et al. Factors associated with failure of Bakri balloon tamponade for the management of postpartum haemorrhage. Case series study and systematic review. Healthcare (Basel). 2021;9(3):295.","journal-title":"Healthcare (Basel)"},{"issue":"17","key":"7236_CR30","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3109\/14767058.2013.796354","volume":"26","author":"R Olsen","year":"2013","unstructured":"Olsen R, Reisner DP, Benedetti TJ, Dunsmoor-Su RF. Bakri balloon effectiveness for postpartum hemorrhage: a real world experience. J Matern Fetal Neonatal Med. 2013;26(17):1720\u20133.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"7236_CR31","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/s12884-023-06103-5","volume":"23","author":"N Ghaem Maghami","year":"2023","unstructured":"Ghaem Maghami N, Helfenstein F, Manegold-Brauer G, Amstad G. Risk factors for postpartum haemorrhage in women with histologically verified placenta accreta spectrum disorders: a retrospective single-centre cross-sectional study. BMC Pregnancy Childbirth. 2023;23(1):786.","journal-title":"BMC Pregnancy Childbirth"},{"key":"7236_CR32","doi-asserted-by":"crossref","unstructured":"B-Lynch C, Meyer K, Javaid T. B-Lynch transverse compression suture for PPH Placenta previa bleeding. Nepal J Obstet Gynecol.\u00a02014;18(2):1\u20132.","DOI":"10.3126\/njog.v9i2.11723"},{"key":"7236_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ijscr.2018.05.006","volume":"48","author":"V Seidel","year":"2018","unstructured":"Seidel V, Braun T, Weizs\u00e4cker K, Henrich W. Application of chitosan-covered gauze in combination with intrauterine balloon tamponade for postpartum hemorrhage treatment - case report of a novel uterine sandwich approach. Int J Surg Case Rep. 2018;48:101\u20133.","journal-title":"Int J Surg Case Rep"},{"issue":"7","key":"7236_CR34","first-page":"CD013663","volume":"7","author":"FJ Kellie","year":"2020","unstructured":"Kellie FJ, Wandabwa JN, Mousa HA, Weeks AD. Mechanical and surgical interventions for treating primary postpartum haemorrhage. Cochrane Database Syst Rev. 2020;7(7):CD013663.","journal-title":"Cochrane Database Syst Rev"},{"key":"7236_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ejogrb.2024.07.027","volume":"300","author":"A Shajahan","year":"2024","unstructured":"Shajahan A, Paily Paily V, Sudhamma A, Ambujam K, Joseph Neelankavil J, Usha MG, et al. Postpartum haemorrhage management: a randomized controlled trial comparing transvaginal uterine artery clamp, vacuum-assisted uterine contraction and condom tamponade. Eur J Obstet Gynecol Reprod Biol. 2024;300:337\u201344.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"7236_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ijgo.12498","volume":"142","author":"CW Kong","year":"2018","unstructured":"Kong CW, To WW. Prognostic factors for the use of intrauterine balloon tamponade in the management of severe postpartum hemorrhage. Int J Gynaecol Obstet. 2018;142(1):48\u201353.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"7236_CR37","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/ijgo.14349","volume":"160","author":"TY Xu","year":"2023","unstructured":"Xu TY, Fu Q. Risk factors for Bakri balloon tamponade failure in the management of postpartum hemorrhage. Int J Gynaecol Obstet. 2023;160(2):685\u201390.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"7236_CR38","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1186\/s12884-021-04191-9","volume":"21","author":"S Sugai","year":"2021","unstructured":"Sugai S, Nonaka T, Tamegai K, Sato T, Haino K, Enomoto T, et al. Successful repeated uterine artery embolization in postpartum hemorrhage with disseminated intravascular coagulation: a case report and literature review. BMC Pregnancy Childbirth. 2021;21(1):710.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"7236_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/ijgo.12251","volume":"139","author":"TF Burke","year":"2017","unstructured":"Burke TF, Danso-Bamfo S, Guha M, Oguttu M, Tarimo V, Nelson BD. Shock progression and survival after use of a condom uterine balloon tamponade package in women with uncontrolled postpartum hemorrhage. Int J Gynaecol Obstet. 2017;139(1):34\u20138.","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"7236_CR40","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1515\/jpm-2017-0249","volume":"46","author":"D Wang","year":"2018","unstructured":"Wang D, Xu S, Qiu X, Zhu C, Li Z, Wang Z, et al. Early usage of Bakri postpartum balloon in the management of postpartum hemorrhage: a large prospective, observational multicenter clinical study in South China. J Perinat Med. 2018;46(6):649\u201356.","journal-title":"J Perinat Med"},{"issue":"3","key":"7236_CR41","first-page":"2268","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang Y, Xiao C, Zhang N, Sun G. Performance of Bakri balloon tamponade in controlling postpartum hemorrhage. Am J Transl Res. 2023;15(3):2268\u201379.","journal-title":"Am J Transl Res"},{"issue":"8","key":"7236_CR42","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/1471-0528.14382","volume":"124","author":"M Revert","year":"2017","unstructured":"Revert M, Cottenet J, Raynal P, Cibot E, Quantin C, Rozenberg P. Intrauterine balloon tamponade for management of severe postpartum haemorrhage in a perinatal network: a prospective cohort study. BJOG. 2017;124(8):1255\u201362.","journal-title":"BJOG"},{"key":"7236_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ejogrb.2021.01.030","volume":"258","author":"A Leleu","year":"2021","unstructured":"Leleu A, Ghesquiere L, Machuron F, Caudrelier C, Devouge P, Subtil D, et al. Intrauterine balloon tamponade in the management of severe postpartum haemorrhage after vaginal delivery: is the failure early predictable? Eur J Obstet Gynecol Reprod Biol. 2021;258:317\u201323.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07236-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07236-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07236-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:22:30Z","timestamp":1738732950000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07236-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7236"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07236-5","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adhered to the ethical guidelines laid down in the 1975 Declaration of Helsinki and was approved by the local Ethics Committee on 11\/10\/2021 (EA4\/231\/21). The relevant local guidelines and regulations were followed. Informed consent of the patients to participate was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of personal or clinical details was obtained from all of the participants and from the parents of all participants under the age of 18, respectively.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}